4th Quarter - Report

BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$250,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 20, 2015 $250,000 Replaced
4th Quarter - Amendment Sep 21, 2015 $160,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.3742, Antibiotic Development to Advance Patient Treatment Act of 2013 Issues related to medication errors Issues related to pandemic preparedness Issues related to device regulation Issues related to diagnostic regulation Issues related to biomedical research

LobbyistCovered position, as disclosed
JENNIFER M LURAY —
DANNY LY —
ELIZABETH WOODY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 3742 (113th)

Medicare/Medicaid MMM

Issues related to device payment

LobbyistCovered position, as disclosed
DANNY LY —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Budget/Appropriations BUD

NIH Funding

LobbyistCovered position, as disclosed
JENNIFER M LURAY —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.